<i>N</i>-acetyltransferase 2 Slow Acetylator Genotype Associated with Adverse Effects of Sulfasalazine in the Treatment of Inflammatory Bowel Disease - Concepedia

Concepedia

Publication | Open Access

<i>N</i>-acetyltransferase 2 Slow Acetylator Genotype Associated with Adverse Effects of Sulfasalazine in the Treatment of Inflammatory Bowel Disease

DOI Full Paper Access

55

Citations

15

References

2007

Year

Min Chen, Bing Xia, Bixiao Chen, Qiusha Guo, Li Jin, Mei Ye, Zhengguo Hu

Canadian Journal of Gastroenterology

Abstract

The NAT2 gene polymorphism was not associated with susceptibility to IBD in Chinese populations, but the NAT2 slow acetylator genotypes were significantly associated with SP dose-related adverse effects of SASP in the treatment of IBD.

References

	Year	Citations

Page 1